课题基金 / 基金详情

Optimization and characterization of expanded NKreg cells for therapy of chronic graft-versus-host disease

Optimization and characterization of expanded NKreg cells for therapy of chronic graft-versus-host disease
用于治疗慢性移植物抗宿主病的扩增 NKreg 细胞的优化和表征
批准号：
449621
负责人：
Lauener Madeline
金额：
$1.27万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2021-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=449621&lang=en
关键词：
Cd56 Bright Natural Killer Cells Cell Therapy Chronic Graft-Versus-Host Disease Immune Regulation Immunology Regulatory Natural Killer Cells Transplantation

项目摘要

项目成果

Lauener Madeline的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hematopoietic Stem Cell Transplantation (HSCT) is a critical immune-based therapeutic option for patients with high-risk and relapsed blood cancers. However, HSCT is attributed to an increased risk of complications, the most severe being chronic graft-ver
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization and characterization of expanded CD56bright regulatory natural killer cells for the therapy of chronic graft-versus-host disease.
  • 批准号：
    457612
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $10.93万
  • 财政年份：
    2021
  • 负责人：
    Lauener Madeline
  • 依托单位：
    University of British Columbia
Optimization and characterization of expanded CD56bright regulatory natural killer cells for the therapy of chronic graft-versus-host disease.
海外基金